Skip to main content
Clinical Trials/NCT00210132
NCT00210132
Completed
Phase 2

Randomized Trial to Evaluate the Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery

Institut Bergonié1 site in 1 country90 target enrollmentOctober 1, 2003

Overview

Phase
Phase 2
Intervention
Ropivacaine
Conditions
Postoperative Pain
Sponsor
Institut Bergonié
Enrollment
90
Locations
1
Primary Endpoint
Proportion of Patients With Major Post-operative Pain at Mobilization Following Lung Surgery by Posterolateral Thoracotomy
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

Thoracic surgery via posterolateral thoracotomy causes significant postoperative pain.

There are several methods of postoperative pain relief, including intravenous analgesics and local-regional analgesia techniques. Although thoracic epidural remains the gold standard, it is not without complications, which are rare but serious, and should be reserved for trained teams or patients with high morbidity.

Intrapleural analgesia is a simple method, performed by the surgeon intraoperatively.

Its effectiveness is controversial and the results remain inconsistent. Ropivacaine is a recently marketed local anesthetic with a modest vasoconstrictive effect. The variation in plasma levels of ropivacaine obtained by this technique has not yet been evaluated.

The purposes of this study are:

  1. To determine the efficacy of inter pleural analgesia
  2. To determine the plasmatic concentration of ropivacaine by inter pleural road
Registry
clinicaltrials.gov
Start Date
October 1, 2003
End Date
February 28, 2008
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Thoracotomy for oncology thoracic surgery
  • Secondary or primary cancer
  • American Society of Anesthesiology (ASA) class 1 or 2

Exclusion Criteria

  • Ropivacaine hypersensibility
  • Psychiatric disorders
  • Incapacity of using visual analog scale

Arms & Interventions

Ropivacaine Arm

ropivacaine at 7.5 mg/ml: 4 ml + 4 ml of saline solution to obtain 8 ml of a ropivacaine solution at 3.75 mg/ml injected into the intrapleural catheter every 6 hours. Treatment administration = every 6 hours for 48 hours.

Intervention: Ropivacaine

Reference Arm

8 ml of saline solution will be injected into the intrapleural catheter. Treatment administration = every 6 hours for 48 hours.

Intervention: Reference

Outcomes

Primary Outcomes

Proportion of Patients With Major Post-operative Pain at Mobilization Following Lung Surgery by Posterolateral Thoracotomy

Time Frame: Between surgery and up to 48 hours

Pain is measured using a visual analog scale (VAS), ranging from 0 (no pain) to 100 (worst pain ever). A participant is considered to have major pain if VAS score is \>= 70.

Secondary Outcomes

  • Post-operative Morphine Consumption Following Lung Surgery by Posterolateral Thoracotomy(between surgery and 48 hours)

Study Sites (1)

Loading locations...

Similar Trials